Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

In Vivo Effects of Amylase Trypsin Inhibitors From Wheat in the Human Gut: Proof of Cause of Non-coeliac Wheat Sensitivity in Irritable Bowel Syndrome?

NCT05157867 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT05157867
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05157867 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
In Vivo Effects of Amylase Trypsin Inhibitors From Wheat in the Human Gut: Proof of Cause of Non-coeliac Wheat Sensitivity in Irritable Bowel Syndrome?
Lead sponsor
Maastricht University
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2023
Completion date
September 30, 2024
Enrollment
8 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

irritable bowel syndrome, non-coeliac wheat sensitivity (ncws)